BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 27, 2021
View Archived Issues
FDA clears IND for phase I/II study of LION-101 gene therapy as treatment of LGMD2I/R9
Read More
First-in-human trial of the PET ligand [68Ga]DOTA-Siglec-9 targeting vascular adhesion protein 1
Read More
Preclinical results presented for a gene therapy to treat CDHR1-related retinopathy
Read More
Promising liver-specific AAV gene therapy for glycogen storage disease type 1A
Read More
Amgen initiates phase I study of AMG-994 alone and with AMG-404 in advanced solid tumors
Read More
Prosit Sole initiates phase I study of interferon lambda chimera injection PSP-001
Read More
Telix reports data from phase I/IIa study of TLX-66 in AL amyloidosis
Read More
New G12C mutant KRAS inhibitors discovered at Beijing Jacobio Pharmaceuticals
Read More
New opioid receptor agonists identified at Fudan University
Read More
Tango Therapeutics presents new PRMT5 inhibitors
Read More
Hangzhou Bangshun Pharmaceutical decribes new RET inhibitors
Read More
Bioardis patents CD73 inhibitors
Read More
Amino acid composition AXA-1665 beneficial in Child-Pugh A and B patients
Read More
Studies reveal efficacy of OTL-101 gene therapy in treating ADA-SCID
Read More
NFlection presents positive phase IIa data for NFX-179 gel
Read More
Jasper collaborates with NIAID to evaluate JSP-191 in chronic granulomatous disease
Read More
SPX-1009 leads to suppression of melanoma cells
Read More
Janssen initiates first-in-human trial of JNJ-75276617 in acute leukemia
Read More
Enrollment ongoing in phase I study of IBI-322 in hematologic malignancies
Read More
Novel RIPK2 inhibitor for the treatment of IBD
Read More
GGT7 as new prognostic biomarker in gastric cancer
Read More
Start of phase II/III EMPATHY trial of ensovibep for treatment of COVID-19
Read More
Study casts new light on chronic HCV infection
Read More
Aptevo reports phase I data on APVO-436 in AML and MDS
Read More
First-in-human study of ZB-716 for ER-positive, HER2-negative advanced breast cancer
Read More